MannKind Corp. (MNKD)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
4 |
$259,345 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
01 Aug 2022 |
BINDER STEVEN B. |
Chief Financial Officer |
31 Jul 2022 |
791 |
2.93 |
2,318 |
01 Aug 2022 |
CASTAGNA MICHAEL |
Chief Executive Officer |
31 Jul 2022 |
3,147 |
2.93 |
9,221 |
01 Aug 2022 |
TROSS STUART A |
Chief People & Workpl Officer |
31 Jul 2022 |
4,581 |
2.93 |
13,422 |
01 Aug 2022 |
GALINDO ALEJANDRO |
EVP Endocrine Business Unit |
31 Jul 2022 |
5,000 |
2.93 |
14,650 |
01 Mar 2022 |
GALINDO ALEJANDRO |
Chief Commercial Officer |
28 Feb 2022 |
36,900 |
2.71 |
99,999 |
01 Mar 2022 |
HOOPER ANTHONY C |
Director |
28 Feb 2022 |
40,000 |
2.71 |
108,400 |
01 Mar 2022 |
TROSS STUART A |
Chief People & Workpl Officer |
28 Feb 2022 |
9,225 |
2.71 |
25,000 |
01 Mar 2022 |
CASTAGNA MICHAEL |
Chief Executive Officer |
28 Feb 2022 |
27,675 |
2.71 |
74,999 |
01 Mar 2022 |
GRANCIO JENNIFER |
Director |
28 Feb 2022 |
110,701 |
2.71 |
300,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock